论文期刊

取消

高级检索

检索历史清除

首页> Cell death & disease> Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.

Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.

导出 OA

翻译打印收藏纠错

作者： Yu,Feng ^[1] ; Hongmei,Luo ^[1] ; Jingcao,Huang ^[1] ; Yue,Zhang ^[1] ; Jingjing,Wen ^[2] ; Linfeng,Li ^[1] ; Ziyue,Mi ^[1] ; Qianwen,Gao ^[3] ; Siyao,He ^[1] ; Xiang,Liu ^[1] ; Xinyu,Zhai ^[1] ; Xin,Wang ^[1] ; Li,Zhang ^[1] ; Ting,Niu ^[4] ; Yuhuan,Zheng ^[5]

作者单位： Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China. ^[1] Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.;Department of Hematology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China. ^[2] Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.;School of Life Science, Sichuan University, Chengdu, China. ^[3] Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China. Tingniu@sina.com.cn. ^[4] Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China. zhengyuhuan@scu.edu.cn. ^[5]

主题词人类(Humans);二氢硫辛酰胺脱氢酶(Dihydrolipoamide Dehydrogenase);多发性骨髓瘤(Multiple Myeloma);动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);蛋白酶体内肽酶复合物(Proteasome Endopeptidase Complex);抗肿瘤药(Antineoplastic Agents);小鼠(Mice);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays);NAD(NAD);女(雌)性(Female);男(雄)性(Male);分子靶向治疗(Molecular Targeted Therapy)

DOI 10.1038/s41419-024-06982-2

PMID 39138149

发布时间 2024-09-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cell death & disease

Cell death & disease

2024年15卷8期

588页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷